Eisai
4523.T
#2079
Rank
A$13.57 B
Marketcap
A$48.10
Share price
6.09%
Change (1 day)
6.10%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.25. In 2026 the company made an earnings per share (EPS) of A$1.24 a decrease over its 2025 EPS that were of A$1.57.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026A$1.24-21.04%
2025A$1.5711.85%
2024A$1.41-32.63%
2023A$2.095.52%
2022A$1.98-74.01%
2021A$7.61-66.58%
2020A$22.7798.24%
2019A$11.4917.01%
2018A$9.8237.78%
2017A$7.12-27.62%
2016A$9.8435.33%
2015A$7.27-2.82%
2014A$7.48-27.66%
2013A$10.35-27.49%
2012A$14.27-12.67%
2011A$16.3488.08%
2010A$8.69-11.06%
2009A$9.77-390.15%
2008A-$3.37-127.78%
2007A$12.12347.11%
2006A$2.714.38%
2005A$2.607.4%
2004A$2.4243.03%
2003A$1.6925.09%
2002A$1.3552.67%
2001A$0.8969.76%
2000A$0.52